Trump has rolled back many of his steepest tariffs over recent months, including a sky-high levy on China, the top source of U.S. imports. In recent days, however, Trump announced plans to slap ...

President Trump and his administration have been studying new sectoral tariffs that could cover a broad part of the American ...

The expiration of the enhanced ACA premium subsidies at the end of this year is prompting many insurers to hike rates by an ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

That's the total value of pharmaceuticals China imported last year, up from $27 billion in 2017. Despite Beijing's drive for economic self-sufficiency, it has continued to welcome U.S. medical ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

Key Points Adjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year. Revenue rose 5.8% year over year to $23.7 billion, exceeding estimates by $889 million. Full-year 2025 ...

Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month, making good on months of threats.